cbdMD (YCBD) Change in Accured Expenses (2017 - 2025)

cbdMD has disclosed Change in Accured Expenses across 9 years of filings, most recently posting -$276942.0 for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at -$276942.0, down 16.97% year-over-year; the trailing twelve-month figure through Dec 2025 was -$302055.0 (up 79.91% YoY), and the FY2025 annual result was -$261883.0, up 76.7% from the prior year.
• Change in Accured Expenses came in at -$276942.0 for Q4 2025 at cbdMD, down from -$67251.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $763157.0 in Q2 2021 to a low of -$1.6 million in Q3 2024.
• The 5-year median for Change in Accured Expenses is -$53808.0 (2025), against an average of -$168466.0.
• Across the five-year window, Change in Accured Expenses plunged 1494.93% in 2023 and jumped 20577.44% in 2025, its largest moves.
• cbdMD's Change in Accured Expenses stood at -$127254.0 in 2021, then surged by 130.81% to $39204.0 in 2022, then soared by 262.95% to $142292.0 in 2023, then tumbled by 266.4% to -$236770.0 in 2024, then fell by 16.97% to -$276942.0 in 2025.
• The last three Change in Accured Expenses figures came in at -$276942.0 (Q4 2025), -$67251.0 (Q3 2025), and $82503.0 (Q2 2025), per Business Quant data.